Skip to main content
Clinical Trials/NL-OMON41268
NL-OMON41268
Completed
Not Applicable

Early detection of pulmonary exacerbations in mucociliary clearance diseases: Molecular fingerprinting by exhaled breath and microbiome analysis - Early detection of exacerbations in mucociliary clearance diseases

Academisch Medisch Centrum0 sites100 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Academisch Medisch Centrum
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \* CF diagnosis is based on: clinical symptoms in combination with an abnormal sweat test (chloride \> 60 mmol/l) and/or identification of mutations in both alleles of the CFTR gene.
  • \* PCD diagnosis is based on: a combination of clinical symptoms, abnormal movement of cilia on microscopic evaluation of respiratory epithelial biopsies and epithelial cell cultures, or identification of an ultra structural defect in the cilia by electron microscopy.
  • \* \* 6 years of age
  • \* Stable respiratory disease for at least 6 weeks ( as determined by the treating physician)
  • \* Ability to perform lung function measurement

Exclusion Criteria

  • \* Mental retardation
  • \* Diabetes Mellitus (CF complication)
  • \* Technical unsatisfactory performance of measurements
  • \* On the waiting list for lung transplantation
  • \* Participation in the PREVEC or VERTEX study (AMC)

Outcomes

Primary Outcomes

Not specified

Similar Trials